Invitae Breast Cancer STAT Panel Expansion
Invitae has launched an expansion of its Breast Cancer STAT panel. The expansion contains two additional breast cancer predisposition genes — ATM and CHEK2 — and a faster turnaround time with results available in as few as five days at no additional cost. The panel also includes seven well-established genes associated with a significantly increased risk of developing breast cancer: BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, and TP53. Testing is available for both blood and saliva samples.